Cancer Research · 2013 · 181 citations · 40 references
MedicineOncologyPharmacologyMolecular PharmacologyNeuropharmacologySensory PhysiologyNeuropathic PainNeuropathic Pain PharmacotherapyPain NeurobiologyPain PhysiologyTumor-related Pain SyndromesCancer Pain PathophysiologyCancer-related Neuropathic PainDrug-induced Peripheral NeuropathyIon Channel SelectivityNociceptive Pain PharmacotherapyPain Mechanisms In CancerPain Signaling PathwaysTrp Channel Signaling
Chemotherapy-induced peripheral neuropathy (CIPN) is a severe and painful adverse reaction of cancer treatment in patients that is little understood or treated. Cytotoxic drugs that cause CIPN exert their effects by increasing oxidative stress, which activates the ion channel TRPA1 expressed by nociceptors. In this study, we evaluated whether TRPA1 acted as a critical mediator of CIPN by bortezomib or oxaliplatin in a mouse model system. Bortezomib evoked a prolonged mechanical, cold, and selective chemical hypersensitivity (the latter against the TRPA1 agonist allyl isothiocyanate). This CIPN hypersensitivity phenotype that was stably established by bortezomib could be transiently reverted by systemic or local treatment with the TRPA1 antagonist HC-030031. A similar effect was produced by the oxidative stress scavenger α-lipoic acid. Notably, the CIPN phenotype was abolished completely in mice that were genetically deficient in TRPA1, highlighting its essential role. Administration of bortezomib or oxaliplatin, which also elicits TRPA1-dependent hypersensitivity, produced a rapid, transient increase in plasma of carboxy-methyl-lysine, a by-product of oxidative stress. Short-term systemic treatment with either HC-030031 or α-lipoic acid could completely prevent hypersensitivity if administered before the cytotoxic drug. Our findings highlight a key role for early activation/sensitization of TRPA1 by oxidative stress by-products in producing CIPN. Furthermore, they suggest prevention strategies for CIPN in patients through the use of early, short-term treatments with TRPA1 antagonists.
40
Quantitative assessment of tactile allodynia in the rat paw
Sandra R. Chaplan, Flemming W. Bach, J W Pogrel et al. · Journal of Neuroscience Methods · 1994 · 7.9K citations
ANKTM1, a TRP-like Channel Expressed in Nociceptive Neurons, Is Activated by Cold Temperatures
Gina M. Story, Andrea Peier, Alison J. Reeve et al. · Cell · 2003 · 2.5K citations · Full text
TRPA1 mediates formalin-induced pain
Colleen R. McNamara, Josh Mandel-Brehm, Diana M. Bautista et al. · Proceedings of the National Academy of Sciences · 2007 · 1.3K citations · Full text
Marcello Trevisani, Jan Siemens, Serena Materazzi et al. · Proceedings of the National Academy of Sciences · 2007 · 762 citations · Full text